Invitrogen bought Molecular Probes in 2003 for approximately $325 million in cash.
The Gateway Technology provides a quick and highly efficient way to move genes into a multiple vector system for functional analysis and protein expression (Invitrogen, Gateway Technology Manual, 2003).
Gateway Destination vectors are commercially available from Invitrogen, EMD (Novagen) and Covalys.